Fig. 4From: Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case reportAfter four courses of nivolumab, the size of the metastatic lymph node was 34 mm × 31 mm (arrow)Back to article page